GB1360536A - Pyridoxyl-l-aspartic acid salt - Google Patents

Pyridoxyl-l-aspartic acid salt

Info

Publication number
GB1360536A
GB1360536A GB1950072A GB1950072A GB1360536A GB 1360536 A GB1360536 A GB 1360536A GB 1950072 A GB1950072 A GB 1950072A GB 1950072 A GB1950072 A GB 1950072A GB 1360536 A GB1360536 A GB 1360536A
Authority
GB
United Kingdom
Prior art keywords
pyridoxyl
aspastate
monopotassium
acid salt
aspartic acid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired
Application number
GB1950072A
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Societe dEtudes de Produits Chimiques SA
Original Assignee
Societe dEtudes de Produits Chimiques SA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Societe dEtudes de Produits Chimiques SA filed Critical Societe dEtudes de Produits Chimiques SA
Priority to GB1950072A priority Critical patent/GB1360536A/en
Priority to FR7310228A priority patent/FR2181843B1/fr
Publication of GB1360536A publication Critical patent/GB1360536A/en
Expired legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D213/00—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members
    • C07D213/02—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members
    • C07D213/04—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom
    • C07D213/60—Heterocyclic compounds containing six-membered rings, not condensed with other rings, with one nitrogen atom as the only ring hetero atom and three or more double bonds between ring members or between ring members and non-ring members having three double bonds between ring members or between ring members and non-ring members having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D213/62—Oxygen or sulfur atoms
    • C07D213/63—One oxygen atom
    • C07D213/65—One oxygen atom attached in position 3 or 5
    • C07D213/66—One oxygen atom attached in position 3 or 5 having in position 3 an oxygen atom and in each of the positions 4 and 5 a carbon atom bound to an oxygen, sulphur, or nitrogen atom, e.g. pyridoxal

Abstract

1360536 Pyridoxyl aspastate salt SOC E ETUDES DE PRODUITS CHIMIQUES 30 March 1973 [25 April 1972] 19500/72 Heading C2C Monopotassium pyridoxyl - l - aspastate of formula is prepared by reacting pyridoxal with dipotassium - l - aspastate and reducing in situ with HBH 4 the Schiffs base so formed followed by addition of mineral acid to yield the monopotassium slat. Pharmaceutical compositions in conventional forms having cardiac analeptic activity comprise the above compound and carriers or diluents.
GB1950072A 1972-04-25 1972-04-25 Pyridoxyl-l-aspartic acid salt Expired GB1360536A (en)

Priority Applications (2)

Application Number Priority Date Filing Date Title
GB1950072A GB1360536A (en) 1972-04-25 1972-04-25 Pyridoxyl-l-aspartic acid salt
FR7310228A FR2181843B1 (en) 1972-04-25 1973-03-22

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB1950072A GB1360536A (en) 1972-04-25 1972-04-25 Pyridoxyl-l-aspartic acid salt

Publications (1)

Publication Number Publication Date
GB1360536A true GB1360536A (en) 1974-07-17

Family

ID=10130402

Family Applications (1)

Application Number Title Priority Date Filing Date
GB1950072A Expired GB1360536A (en) 1972-04-25 1972-04-25 Pyridoxyl-l-aspartic acid salt

Country Status (2)

Country Link
FR (1) FR2181843B1 (en)
GB (1) GB1360536A (en)

Cited By (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288716A (en) * 1987-02-18 1994-02-22 Ulrich Speck Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US2542869A (en) * 1948-03-19 1951-02-20 Merck & Co Inc N-pyridoxyl-amino acids and process of preparing the same

Cited By (25)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5288716A (en) * 1987-02-18 1994-02-22 Ulrich Speck Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis
US6066659A (en) * 1987-02-18 2000-05-23 Steigerwald Arzneimittelwerk Gmbh Use of pyridoxine derivatives in the prevention and treatment of hyperlipidaemia and atherosclerosis
US6043259A (en) * 1998-07-09 2000-03-28 Medicure Inc. Treatment of cardiovascular and related pathologies
US7230009B2 (en) 1999-03-08 2007-06-12 Medicure, Inc. Pyridoxal analogues and methods of treatment
US6339085B1 (en) 1999-03-08 2002-01-15 The University Of Manitoba Therapeutics for cardiovascular and related diseases
US6890943B2 (en) 1999-03-08 2005-05-10 Medicure Inc. Pyridoxal analogues and methods of treatment
US6489345B1 (en) 1999-07-13 2002-12-03 Medicure, Inc. Treatment of diabetes and related pathologies
US6677356B1 (en) 1999-08-24 2004-01-13 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7125889B2 (en) 1999-08-24 2006-10-24 Medicure International Inc. Treating of cardiovascular and related pathologies
US7144892B2 (en) 1999-08-24 2006-12-05 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7148233B2 (en) 1999-08-24 2006-12-12 Merrill Lynch Capital Canada Inc. Treatment of cardiovascular and related pathologies
US7132430B2 (en) 1999-08-24 2006-11-07 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115625B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US7115626B2 (en) 1999-08-24 2006-10-03 Medicure International Inc. Treatment of cardiovascular and related pathologies
US6605612B2 (en) 2000-02-29 2003-08-12 Medicure International Inc. Cardioprotective phosohonates and malonates
US6667315B2 (en) 2000-02-29 2003-12-23 Medicure International Inc. Cardioprotective phosphonates and malonates
US6780997B2 (en) 2000-02-29 2004-08-24 Medicure International Inc. Cardioprotective phosphonates and malonates
US6867215B2 (en) 2000-02-29 2005-03-15 Medicure International Inc. Cardioprotective phosphonates and malonates
US7105673B2 (en) 2000-02-29 2006-09-12 Medicure International Inc. Cardioprotective phosphonates and malonates
US6861439B2 (en) 2000-03-28 2005-03-01 Medicure International, Inc. Treatment of cerebrovascular disease
US6586414B2 (en) 2000-03-28 2003-07-01 Medicure International Inc. Treatment of cerebrovascular disease
US6897228B2 (en) 2000-07-07 2005-05-24 Medicure International Inc. Pyridoxine and pyridoxal analogues: new uses
US6417204B1 (en) 2000-07-07 2002-07-09 Medicure International Inc. Pyridoxine AMD pyridoxal analogues: cardiovascular therapeutics
US6548519B1 (en) 2001-07-06 2003-04-15 Medicure International Inc. Pyridoxine and pyridoxal analogues: novel uses
US7812037B2 (en) 2004-10-28 2010-10-12 Medicure International, Inc. Dual antiplatelet/anticoagulant pyridoxine analogs

Also Published As

Publication number Publication date
FR2181843B1 (en) 1976-05-21
FR2181843A1 (en) 1973-12-07

Similar Documents

Publication Publication Date Title
ES344357A1 (en) Cyclopropanecarboxylic acid esters
GB1325192A (en) Phloroglucinol derivatives
GB1360536A (en) Pyridoxyl-l-aspartic acid salt
GB1333471A (en) Imidazoline derivatives and process for preparing the same
GB1382782A (en) Alkylarylketones processes for their preparation and compositions incorporating them
GB1380225A (en) Biphenylyl- alkanoylaminopyridines and acid addition salts thereof
GB1236531A (en) Adenin derivative
GB1336037A (en) Mercapto carboxylic acid esters
IE36127L (en) 3-benzylpyridines
GB1325386A (en) Quinazoline derivatives processes for producing them and compositions containing them
GB1343587A (en) Process for the preparation of derivatives of beta-phenylpyruvic acid
GB1292410A (en) Thienobenzothiazepine derivatives
GB1411700A (en) Penicillins and production thereof
GB1384843A (en) Benzofuran derivatives their preparation and compositions containing them
GB1412932A (en) Pharmaceutically active leurosine derivatives and preparation thereof
GB1259685A (en) Amino-pyrimidine derivatives
GB1429697A (en) Method for producing isonitrosomalonic esters
GB1224619A (en) DERIVATIVES OF alpha-AMINOPENICILLINS
GB1333510A (en) Malonyl urea derivatives process for their preparation and compositions incorporating them
GB1261594A (en) Novel 3-arylimino-4,5-dichloro-1,2-dithioles, processes for their production and compositions containing them
GB1341612A (en) Theophylline isobutyrate salts and process for the preparation thereof
GB1271016A (en) Novel pyrrolidine derivatives, and processes for their preparation
GB1471371A (en) Cyclopenteno-b-pyridine derivative
GB1388325A (en) Benzodioxan derivatives
GB1467385A (en) Pharmaceutical compositions containing 2-imino-thiazol- idine derivatives

Legal Events

Date Code Title Description
PS Patent sealed
PCNP Patent ceased through non-payment of renewal fee